Добавил:
Upload Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Protokoly_diagnostiki_i_lechenia_zabolevany

.pdf
Скачиваний:
21
Добавлен:
06.02.2015
Размер:
2.14 Mб
Скачать

4.Hanus PM, Danzinger LH. Treatment of chronic bacterial prostatitis. Clin Pharm 1984; 3: 49-55;

5.McNaughton, C.M. and Wilt, T. (2001) Allopurinol for chronic prostatitis (Cochrane Review). The Cochrane Library (Issue 1). Oxford: Update Software;

6.Collins M, MacDonald R, Wilt T. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann Intern Med 2000; 133: 367-368;

7.McNaughton Collinns M, MacDonald R, Wilt T. Interventions for chronic abacterial prostatitis. In: The Cochrane Library, Issue 3, 2001.

* – , # (% % ) .

;: 02-018

"$ &: " :

& !: ' @, .

' & & ( ): 9

(: H40.5 "

) : " – , $#(' @), ,$# " ( 3 ) & & & "" .

$ :

$ %$, ,, $ ' @, %$ & " .

%$: " , " , ".

: % , $& , .

' @: & , & ,, .

$ ' @: , ; & ,' @.

% & : " & , , , & .

"$ ( & ): , . * : . ". B$# " % . . ! . ! &. & .

" :

" : " $# , & , ' @

5 : 7 , & , , , , , ?6, ? , , , ?J;,

?!;, 'BL, $, 3 , & .

 

 

 

: ' @,

&

,

 

 

,

" , %

 

,

%

 

,

3 & .

 

 

 

 

 

" &

:

 

 

 

 

2.<

3.;

7.&

8.&

" & & :

1.H)B

2.7

3.B " " &

4.7

5." B J

6.;

8. ' ( )

9.?J;

10.?!;

11.'BL

+ :

1. # % ' @ –250 1 4 & 1-3 , 0,5% 2 & -1-3 ; 1-2 &, 1-3 , 20% 2 / 1 & 1-3 ; .

2. H $# – 3& 3 B J.% & # , .

: 6 ": , ' @, , % @ :

13.42 6 " " 13.20 ' 3 3 12.64 ; 3 %

13.71 ' 3

 

 

 

 

 

 

12.31

J

 

 

 

 

 

12.14

@ 3 ( )

 

 

 

1.

 

3

 

"

& 3 " .

 

 

 

2.

 

? &

 

&

 

 

 

& % – 0,25% 4 & – 70,1% 1 6 & & -7 , & – - 1

1 & – 3 , , 25 1 3 & 7-10 .

 

 

3.

 

%

 

 

-

&

 

& $#

:

0,5-1

&

V - 8 , 2

4 & 6-9 ,

 

1

3 & 5-8 ,

& V 0,5 7 ;

/ V 1 2 & 7 ,

$ 40% ,

5% 0,5

&

4,0 " , 0,02% 2 6

&.

 

 

 

 

 

 

 

 

 

 

 

 

 

%

3

 

"

 

 

 

90 1 & 6-9 .

 

 

 

 

 

4. .

 

 

 

 

 

 

 

 

 

 

" - " 7 ,

% " - 10 .

" & :

 

 

 

 

 

 

 

1. *@ & %

20

 

 

 

 

2.*G

3.*@ ( ) 0,1% 10

4.*@ 25 , 100 , 150 ,

5.* V 1 /30

6.

*? ( ) ( & ) 0,1%, 0,5%, 1% 1

7.

* V 40 / , 80 /2

8.@

9.*? V 5%, 10% 2 , 5

10.*+

11.* V 30 /

12.*; 0,5%, 1% 5

" & & :,- !: ' @

/ , & :

1.EBM Guidelines. Glaucoma. 2004.

2.Rossetti L., Marchetti I., Orzalesi N. Randomised clinical trials on medical treatvent of glaucoma: are they appropriare to guide clinical practice? // Arch. Ophalmol/ - 1993, 111: 96-103.

3.Glaucoma Laser Trial Group. The glaucoma laser trial (GLT) and glaucoma laser trial follow-up study: results. Am. J. Ophtalmol 1995, 120: 718-731.

4.Migdal C, Gregory W., Hitchins R., Kolker AE. Long-term functional outcome after early surgery compared with laser and medicine in open angle glaucoma. Ophthalmology 1994, 105: 1651-1657.

5.Collaborative normal-tension glaucoma study group. The effectiveness of intraocular pressure reduction in the treatment of normal 0tension glaucoma. Am.J.Ophtalmol 1998, 126: 498-505.

6.Edwards RS. A comparative study of Ocuset Pilo 40, intensive pilocarpine and low-dose pilocarpine in the initial treatment of primary acute angle-closure glaucoma. Curr Med Res Opin 1997, 13: 501-509.

* – , # (% % ) .

;

: 22-177

"$ &: " :

& ! : , % . " , ,, 3 % " #- (-, -) , " . # & " " .

' & & ( ): 30

(:

;84 % , " ,

M86

) : G " – 3 , $# "-" " # ( ), & #$#

,

, %$.

 

$ :

& $:

 

1)

 

; 2) & ; 3)

"

& ; 4) ; 5)

 

.

 

 

 

$ $ (J !.?.):

?.

, % :

1.

 

 

 

 

2.

 

 

%

 

3.

 

 

"

 

<.

:

 

 

2.:

" ( , % , 3 .)

(-, -, , 3 )

– , , .

+ % ( % , -, % )

! "

'. " :

2."

3."

4.-3 "

5."

. " "$:

3.G "

>. % :

1.6 :

O %

+ %

2.# :

?

?

+

!

D. :

1.3 ( % & , & , )

2.3 ( & , & )

3.3 &

4.3 &

). " :

1.

" % ( , , "

 

& )

2.- " % , -

3." % ( % , ,, )

4.! ( , " , )

' % " , " , [ "$ : "$ ($), "$ "$.

* : ; % # (- , , ), %

, &

 

, "

$ (3 "

<-J ); " " :

& % & ,

%

"$ ( " @ % ).

 

"

:

 

 

"

: ; G "

,

"

,

 

, .

 

5 : ? , ?6, , $.

: , $ . $# , " % – ;

,

 

& – "

; %

.

 

 

" & :

1. % 2

 

2.#

3.!-

4.< "

5."

6. < " "

7.;

8.O6 ; %

9.H)B

10.HbsAg, Anti-HCV.

" & & :

+ :

(-& )– . " &

&

3- 4-

 

 

 

 

 

( ),

( )

 

 

 

 

 

( , ,

). H" $ &

, $ $ " &

, &

" 24 " . ) 3 & "-"$ $ , " %, 3 , & & - . ' ( " ) .

% ,$ 3$" . V % % & ,&$# - , "- $# . " && - " 1-2 & # , " & & 3 .

; " " (G ) % & & & & V . ! &

 

& ,

,

 

"

G

$

( & ,

" "

). $"

 

"-"

 

G .

! "

&

, " 3 &

 

" % ,

$ % ( , .)

# ( ) . $ $ V ,( , , % " " %$# ). +& 3 3 " , ,. . . ' " 2-3 & &

.

" $" $

 

.

B$"

$ " G ,

 

& . @

" & ( ) " G

" ( , " " ),

-,

 

& &

,

( ) &:

, -&

& . @ "& 100% &

-&

( 3 , 3 , . .)% . B 3 " " &

3 ( , & , % , H_ ). & - 3 , " - & " G , " " # . B " # "

& . 7 &, , , " , . ., - $#& , & ( ) " . @ , " " , %$# & ( -& ) , &

& & , " G " % . "G $ ( &$) . & - & .

# ( ) " & G %$" & $# :

1.! & & ( " G - & % , % # , V . .).

2.H & % .

3.

' & & %

V .

 

 

4.

 

$ " .

 

 

5.

;

 

%

"

% ,

"$#

% &

3

3

 

 

.

6.) & &" # % ", &- ( ," % ).

7.) 3 " , "

& " " 3 , % " & % & .

8. ) % && V % ( ).

9.' & " % &$ & - $ .

10." & & , 3 , , % ( % , " % , ,

% " ) 3 ("

" ) & .

11. J$ ( )

& G

( "

# , " -

. - , "$ & , $# ,

$#

" ) % & .

12. _

" "

&

; & ,

"

.

13.".

14.+ # - &,.

! " $ (

 

" ) $"

 

 

 

.

< & # ,

G %

$

" % .

' & % &

( ,

 

 

 

). < & ,( & , ,), % " ,

( $" , & )." %" ,& " :, 3 & " " $# #" , " ,- & " , ,

& $#

&

. '

 

 

,

 

&

" " &

(

3-4

,

,

,

,

 

),

 

 

(

, ,

.

,

), $# "$# $

( , ,

$, .), (3 . , !) ,

 

, , ), ,

( ), "$ ( ,

, ', ?, !, >), ( , $).

@ "

 

 

&

 

& 400 \ " 21 . '

 

,

" (H_,

3 , H'L- .), J_, " . %

%

, & &

" .

 

" & :

1.

*/

V 250 , 500 , 1 000

 

 

 

2.

*? V 500 /2

3.

*/ 250 , 500

4.

*6 0,5 100

5.

*B & 150 – 10 \

6.

* , " , #$# (3 ,

 

!) ,

, , )

7.*? V 5%, 10% 2 , 5

8.* 1

9.*; V 5% 1

10.*/ V 1 (500 )

" & & :

,- ! :

" " .

/ , & :

1.?.?., !$& '.'. ";

2.http://www.clevelandclinic.org/health/, Osteomyelitis;

3.http://www.nlm.nih.gov/medlineplus, Osteomyelitis, 2004;

4.K ?. ., ! " & " ;

5.? M.?., < B.'. G " –" .

* – , # (% % ) .

' & 8 . # !

: 12-120

 

 

"$ &: "

 

 

:

 

 

& ! : & %

 

' & & ( ): 18

 

 

(: N40 & %

 

) : ' & 8

(';"W) -

$ ,

$#

 

& & % ,

# % "

. @ @ D & " (1). " & "( " # " , " , & " , " , % ,

# # % "

, ).

$ :

 

 

I - ,

"

, " " .

II - ,

"

, " " " .

III - , " , " V " " , " % " .

* : % , " , $#(G +, " )

" : 3

" & :

1.# (6 )

2.# "

3.( , , , " , " & , )

4."

5.$

7.;

8.

9."

10.7

11._ $

12.6

13.'

14.&

15.& "

16.H)B "

17.H)B "

18.H)B " "

19.HbsAg, Anti-HCV.

" & & :

1.H

2.H)B $

+ :

Соседние файлы в предмете [НЕСОРТИРОВАННОЕ]